GENO.STGENO.STSTO
Loading
EBITDA Over TimeContracting
Percentile Rank86
3Y CAGR+38.7%
5Y CAGR+35.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+38.7%/yr
vs +63.7%/yr prior
5Y CAGR
+35.9%/yr
Consistent
Acceleration
-25.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$39.77M-29.2%
2024$56.18M-15.9%
2023$66.84M+348.3%
2022$14.91M-48.4%
2021$28.88M+236.8%
2020$8.57M-49.6%
2019$17.02M+718.9%
2018$2.08M+133.4%
2017$-6.23M+53.8%
2016$-13.48M-